Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, Ghamande S, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Shapiro NI, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Exline MC, Gong MN, Mohamed A, Henning DJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CL, Busse LW, Ten Lohuis CC, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Halasa N, Chappell JD, Lauring AS, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Rhoads JP, Lindsell CJ, Hart KW, Zhu Y, Olson SM, Kobayashi M, Verani JR, Patel MM, Influenza and Other Viruses in the Acutely Ill (IVY) Network
JAMA. 2021 326 (20): 2043-2054

PMID: 34734975 · PMCID: PMC8569602 · DOI:10.1001/jama.2021.19499

MeSH Terms (17)

2019-nCoV Vaccine mRNA-1273 Adult Aged BNT162 Vaccine Case-Control Studies COVID-19 COVID-19 Vaccines Disease Progression Female Hospitalization Humans Male Middle Aged Respiration, Artificial SARS-CoV-2 Severity of Illness Index Vaccination

Connections (1)

This publication is referenced by other Labnodes entities: